Taysha Gene Therapies, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 20.00 M | $34.60 M | 7.24% | 7.47% |
| FMR LLC | 02/13/2025 | 16.37 M | $28.31 M | -12.38% | 6.11% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 13.53 M | $23.41 M | 0.08% | 5.05% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 10.87 M | $18.81 M | 0.00% | 4.06% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 10.45 M | $18.08 M | 128.55% | 3.90% |
| VANGUARD GROUP INC | 02/11/2025 | 8.91 M | $15.41 M | 7.76% | 3.33% |
| RTW INVESTMENTS, LP | 02/14/2025 | 8.67 M | $15.00 M | -41.98% | 3.24% |
| SIREN, L.L.C. | 02/14/2025 | 6.60 M | $11.42 M | 35.30% | 2.47% |
| STATE STREET CORP | 02/14/2025 | 6.47 M | $11.20 M | 86.63% | 2.42% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 5.00 M | $8.65 M | 100.00% | 1.87% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 4.00 M | $6.93 M | 0.00% | 1.50% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 02/14/2025 | 3.70 M | $6.40 M | 0.00% | 1.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 3.57 M | $6.18 M | 0.27% | 1.33% |
| VR ADVISER, LLC | 02/14/2025 | 3.23 M | $5.58 M | -64.16% | 1.20% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 3.00 M | $5.19 M | -0.83% | 1.12% |
| JPMORGAN CHASE & CO | 02/12/2025 | 2.64 M | $4.57 M | -11.92% | 0.99% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 1.64 M | $2.83 M | 43.55% | 0.61% |
| NORGES BANK | 02/12/2025 | 1.46 M | $2.53 M | 100.00% | 0.55% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.03 M | $1.78 M | 0.00% | 0.38% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 967,144 | $1.67 M | -19.78% | 0.36% |
| 02/14/2025 | 965,556 | $1.67 M | 100.00% | 0.36% | |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 884,244 | $1.53 M | -58.27% | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 878,448 | $1.52 M | 100.00% | 0.33% |
| PALO ALTO INVESTORS LP | 02/14/2025 | 811,268 | $1.40 M | 0.00% | 0.30% |
| QUANTUM PRIVATE WEALTH, LLC | 01/30/2025 | 794,976 | $1.38 M | 3.56% | 0.30% |
| SANDS CAPITAL VENTURES, LLC | 02/13/2025 | 724,873 | $1.25 M | 0.00% | 0.27% |
| ALPHABET INC. | 02/07/2025 | 640,882 | $1.11 M | 0.00% | 0.24% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 585,594 | $1.01 M | 26.43% | 0.22% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 546,414 | $945,297 | -3.61% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 522,500 | $903,925 | 100.00% | 0.20% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 474,257 | $820,465 | 2.46% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 450,261 | $778,951 | 33.11% | 0.17% |
| UBS GROUP AG | 02/14/2025 | 421,396 | $729,016 | 358.03% | 0.16% |
| BARCLAYS PLC | 02/13/2025 | 335,238 | $587,000 | 35.57% | 0.13% |
| CITIGROUP INC | 02/12/2025 | 253,292 | $438,195 | 91.00% | 0.09% |
| RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 252,257 | $436,405 | 100.00% | 0.09% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 211,842 | $366,487 | 105.43% | 0.08% |
| RHUMBLINE ADVISERS | 01/30/2025 | 192,079 | $332,287 | 3.13% | 0.07% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 177,707 | $307,433 | -29.31% | 0.07% |
| JANE STREET GROUP, LLC | 02/14/2025 | 169,575 | $293,364 | 57.64% | 0.06% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 151,614 | $262,292 | 100.00% | 0.06% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 151,083 | $261,374 | -94.10% | 0.06% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 142,463 | $246,461 | -19.28% | 0.05% |
| MARSHALL WACE, LLP | 02/13/2025 | 138,111 | $238,932 | -71.58% | 0.05% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 137,460 | $237,806 | -33.59% | 0.05% |
| PRIVIUM FUND MANAGEMENT B.V. | 02/11/2025 | 134,900 | $233,377 | 12.42% | 0.05% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 01/24/2025 | 116,044 | $223,965 | -1.80% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 108,604 | $187,885 | 23.34% | 0.04% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 108,250 | $187,273 | 0.00% | 0.04% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 107,544 | $186,000 | 100.00% | 0.04% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Taysha Gene Therapies, Inc. institutional Ownership - FAQ's
During the previous two years, 140 institutional investors and hedge funds held shares of Taysha Gene Therapies, Inc.. The most heavily invested institutionals were:
Avoro Capital Advisors LLC: 20 M
FMR LLC: 16.37 M
BlackRock Funding, Inc. /DE: 13.53 M
RA CAPITAL MANAGEMENT, L.P.: 10.87 M
Octagon Capital Advisors LP: 10.45 M
VANGUARD GROUP INC: 8.91 M
62.39% of Taysha Gene Therapies, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 170.38 M shares in the last 24 months. This purchase volume represents approximately $349.27 M in transactions.